This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients. The post FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients appeared first on MedCity News.
This week, longtime healthcare veterans Amy Abernethy and Brad Hirsch teamed up to launch Highlander Health — a Dallas-based startup focused on accelerating clinical evidence generation. The post Why Former FDA & Verily Exec Amy Abernethy Is Launching a New Venture appeared first on MedCity News.
Two execs from the Illinois-based health system win awards from the American Telemedicine Association for expanding digital care access
Medicaid financing is complex. This policy watch explains how Medicaid financing works, describes various conservative proposals to change Medicaid financing, and explores the implications of those changes for states and enrollees.
OAKLAND, Calif. — Rosa María Carranza leaned forward to hold a 3-year-old’s back as the girl climbed a rock in the forested hills of northeast Oakland. Dressed in hiking gear and beaded necklaces, Carranza, 67, maneuvered between trees and children on a sunny morning in December. “Hold on to that branch,” she said in Spanish….
Jessie Mazar squeezed the grab handle in her husband’s pickup and groaned as contractions struck her during the 90-minute drive from her home in rural northeastern California to the closest hospital with a maternity unit. She could have reached Plumas District Hospital, in Quincy, in just seven minutes. But it no longer delivers babies. Local…
Value-based care contracting is especially difficult for behavioral health providers, Taft Parsons III, chief psychiatric officer at CVS Health/Aetna, pointed out during a conference this week. The post Aetna Exec: Payers Need to Stop Making Behavioral Health Providers Jump Through Hoops In Order to Participate in Value-Based Care appeared first on MedCity News.
Uno de los dos programas de formación de enfermeras parteras de California ha dejado de admitir estudiantes mientras renueva su plan de estudios para ofrecer sólo doctorados, una medida que ha generado protestas de ex alumnos, expertos en políticas de salud y profesores que acusan a la Universidad de California (UC) de anteponer beneficios económicos…
Insmed’s Brinsupri is the first drug specifically approved for treating non-cystic fibrosis bronchiectasis, a progressive and potentially fatal lung disorder. The drug, licensed from AstraZeneca, inhibits activation of neutrophils, white blood cells that play a role in inflammatory and immune responses. The post Chronic Lung Disease in Medical Literature for More Than 200 Years Finally…
EY report shows a $9 increase in benefits from the prior year